FindTrial
Sign In

Observation of decrease in serum phosphate levels in pregnant women and in women who underwent recent delivery after receiving intra venous iron preparation

Prevalence of Hypophosphatemia in Antenatal And Postpartum women receiving parenteral (intravenous) Iron preparation-A Longitudinal Observational Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075866
Enrollment
90
Registered
2024-10-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O94- Sequelae of complication of pregnancy, childbirth, and the puerperium

Interventions

Intervention1: Parenteral Iron: Given for moderate Anemia in the form intravenous preparation. Inj FCM given intravenous as a single dose of 500mg,750mg or 1gm depending upon iron deficit. Inj Iron Su

Sponsors

Dr Tanvi Hemant Karambelkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant and post partum women having recieved parenteral iron preparation for iron deficiency anemia From 12 weeks gestation to 7 days postpartum

Exclusion criteria

Exclusion criteria: Have known blood dyscrasias Have known renal pathology, hyperparathhyroidism Have recieved previous blood transfusion

Design outcomes

Primary

MeasureTime frame
To study the prevalence of hypophosphatemia in antepartum and postpartum women recieving parenteral (intravenous) iron preparation.Timepoint: Baseline, 6 weeks , 12 weeks—

Secondary

MeasureTime frame
to study the Complications of hypophosphatemia if presentTimepoint: 6th week and 12th week after administration of parenteral iron—

Countries

India

Contacts

Public ContactDr M.C. Metgud

Jawaharlal Nehru Medical College

metm67@gmail.com9164693333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026